Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
about
Invasive mold infections in solid organ transplant recipientsInfluenza-Associated Aspergillosis in Critically Ill Patients.Rapid detection and identification of mucormycetes in bronchoalveolar lavage samples from immunocompromised patients with pulmonary infiltrates by use of high-resolution melt analysisEpidemiology and treatment approaches in management of invasive fungal infectionsAntifungal efficacy of itraconazole-loaded TPGS-b-(PCL-ran-PGA) nanoparticles.Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: clinical evaluation of an extended reference spectra library.Recommendations for Risk Categorization and Prophylaxis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Expert Opinion (TEO-4).Combining standard clinical methods with PCR showed improved diagnosis of invasive pulmonary aspergillosis in patients with hematological malignancies and prolonged neutropeniaHow I treat mucormycosis.Incidence and characteristics of invasive fungal diseases in allogeneic hematopoietic stem cell transplant recipients: a retrospective cohort studyPreclinical evaluation of two 68Ga-siderophores as potential radiopharmaceuticals for Aspergillus fumigatus infection imaging.Prognosis of invasive pulmonary aspergillosis in patients with hematologic diseases in Korea.Risk factors and impact of non-Aspergillus mold infections following allogeneic HCT: a CIBMTR infection and immune reconstitution analysis.Pre-chemotherapy risk factors for invasive fungal diseases: prospective analysis of 1,192 patients with newly diagnosed acute myeloid leukemia (SEIFEM 2010-a multicenter study).Selected ⁶⁸Ga-siderophores versus ⁶⁸Ga-colloid and ⁶⁸Ga-citrate: biodistribution and small animal imaging in miceColonization of a Central Venous Catheter by the Hyaline Fungus Fusarium solani Species Complex: A Case Report and SEM ImagingFebrile neutropenia in children with acute lymphoblastic leukemia: single center experienceSIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients.Pharmacokinetic Assessment of Drug-Drug Interactions of Isavuconazole With the Immunosuppressants Cyclosporine, Mycophenolic Acid, Prednisolone, Sirolimus, and Tacrolimus in Healthy Adults.Emerging invasive fungal diseases in transplantation.Current status of antifungal resistance and its impact on clinical practice.Treatment principles for the management of mold infections.Consensus guidelines for antifungal prophylaxis in haematological malignancy and haemopoietic stem cell transplantation, 2014.Opportunistic infections complicating solid organ transplantation with alemtuzumab induction.Fatal Cases of Bloodstream Infection by Fusarium solani and Review of Published Literature.Vermamoeba vermiformis-Aspergillus fumigatus relationships and comparison with other phagocytic cells.Potential of polymerase chain reaction and galactomannan for the diagnosis of invasive aspergillosis in patients with febrile neutropenia.Risk factors for invasive fusariosis in patients with acute myeloid leukemia and in hematopoietic cell transplant recipients.European Organization for the Research and Treatment of Cancer/Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies.The effect of clinical characteristics on the performance of galactomannan and PCR for the diagnosis of invasive aspergillosis in febrile neutropenic patients.A prospective, randomized study of empirical antifungal therapy for the treatment of chemotherapy-induced febrile neutropenia in children.A retrospective study to describe the epidemiology and outcomes of opportunistic infections after abdominal organ transplantation.Defining Invasive Fungal Infection Risk in Hematological Malignancies: A New Tool for Clinical Practice.Non-Seasonal Variation of Airborne Aspergillus Spore Concentration in a Hospital BuildingEvolution of procalcitonin, C-reactive protein and fibrinogen levels in neutropenic leukaemia patients with invasive pulmonary aspergillosis or mucormycosis.An alternative host model of a mixed fungal infection by azole susceptible and resistant Aspergillus spp strains.Invasive fungal infection in patients receiving chemotherapy for hematological malignancy: a multicenter, prospective, observational study in China.Risk factors for invasive mold diseases in allogeneic hematopoietic cell transplant recipients.Predicting Risk of Infection in Patients with Newly Diagnosed Multiple Myeloma: Utility of Immune ProfilingThe management of febrile neutropenia in the posaconazole era: a new challenge?
P2860
Q26823811-10EC532B-8624-43C3-8B76-C1A5679248AEQ30400852-64602855-BF88-47FB-9542-F68094FC26FFQ34058831-45D2B91E-899D-4F55-8B68-31AF7FAFEC70Q35089772-CA1A57B4-F06F-491B-B6C8-F29FE58BC841Q35110919-A89C6FA3-A950-4E55-9777-3E9F1BDFBE98Q35370259-73AD2C25-9AC4-4114-921C-6D27C9F14984Q35672258-ED15EA2C-7969-4D0A-B591-469FB237F83FQ35678982-7A754944-8124-4743-AED5-18E7C1EC7FDDQ35797637-1059D764-3071-4716-8689-2067BFDB84D5Q35881360-DD3EBC39-79D9-494F-85A8-CE7497D99DD0Q36013562-6186BAD5-A8B4-453F-8D5D-9E471BCCAA9BQ36434278-4CD90876-3CF2-49E6-8731-C89E68A0333AQ36540732-CD25A3E6-1281-4C65-9F88-6FC4AB2A9ADBQ36715906-7542E6EE-1A38-453C-884C-F8109CBC50FBQ36832801-BD037AD0-B22B-4AAA-8542-78C7E4873ADFQ37019810-161FAE99-2465-4EA7-BCBD-C85A554A3F97Q37123565-2E199DCE-C275-4C3D-A3F8-49F240ED341DQ37530914-1028994E-FA77-428B-BBA5-3F81D216E719Q37631892-93742E35-D83D-432A-87CE-49FEECFF4161Q38052084-38C2B18A-83BC-4555-8E0F-1CF16CA4E1FFQ38205859-3CA9AB9F-AB53-4F49-B61A-90611B020D76Q38265845-066E10A0-69F4-48D7-A75E-EB6B0BA10E59Q38284455-1CB014C0-688A-4FF2-8BD7-93870F77BE22Q38558078-8CA8167D-1CD9-402A-961E-971955A7A98EQ38626372-607A2380-4A23-4448-882A-9ECD84FDED43Q38759716-86C65A92-FB3B-4D5B-97CB-D17F719FA04AQ39020600-684909B2-9CDD-4AEF-B055-D34556283042Q39094052-8BE78B71-B0B5-44DF-97C1-260FF8D6667EQ40034587-E05D884E-2080-4A50-B429-B75E3E62CFF4Q40128466-0D2D4F33-7049-4141-94B5-5BE31A21B352Q40287559-874B2BA9-0DFB-4B70-986D-8A90DB0F2AB4Q40302250-D6140830-74B1-4E07-81A3-94FE699B2F8AQ40366168-001F1BC8-3E9A-4379-B7C2-7CA713B0AE03Q40375774-F5F80AF1-D11F-4FB9-B12D-08CF7C4EF852Q40771604-AA4446E8-F2A2-4751-BC20-15A98A9AFE18Q41168999-16FF332C-0BA4-4E86-9CCE-0211504F1C13Q41712164-BC5767AD-5335-4A7D-BA10-89B1F690D044Q42175368-08A60622-84ED-40BA-A471-02D6FE8B99CBQ42373431-B0E2C98E-E186-4ABF-9CAD-63BE755E3726Q43224589-3CED5BE2-C448-47E5-94A5-AD7C5787D9DE
P2860
Risk assessment and prognostic factors for mould-related diseases in immunocompromised patients.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Risk assessment and prognostic ...... in immunocompromised patients.
@en
Risk assessment and prognostic ...... in immunocompromised patients.
@nl
type
label
Risk assessment and prognostic ...... in immunocompromised patients.
@en
Risk assessment and prognostic ...... in immunocompromised patients.
@nl
prefLabel
Risk assessment and prognostic ...... in immunocompromised patients.
@en
Risk assessment and prognostic ...... in immunocompromised patients.
@nl
P2093
P356
P1476
Risk assessment and prognostic ...... in immunocompromised patients.
@en
P2093
George Dimopoulos
Livio Pagano
Lubos Drgona
Nicole Blijlevens
P356
10.1093/JAC/DKQ437
P407
P478
66 Suppl 1
P577
2011-01-01T00:00:00Z